Suven Pharmaceuticals Limited

Founded in 2018 and headquartered in Telangana, India.

2018 | Hyderabad, Telangana (India) | Active
Last Updated:

Suven Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 40.00 Cr
  • Paid Up Capital ₹ 25.46 Cr
  • Company Age 6 Year, 3 Months
  • Last Filing with ROC 31 Mar 2021
  • Open Charges ₹ 174.02 Cr
  • Revenue Growth 47.27%
  • Profit Growth 80.82%
  • Ebitda 59.62%
  • Net Worth 42.76%
  • Total Assets 32.56%

About Suven Pharmaceuticals

Suven Pharmaceuticals Limited (SPL) is a Public Limited Indian Non-Government Company incorporated in India on 06 November 2018 (Six years and three months 26 days old ). Its registered office is in Hyderabad, Telangana, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543064 and on the National Stock Exchange(NSE) under SUVENPHAR.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 25.46 Cr.

The company currently has active open charges totaling ₹174.02 Cr.

The Key Managerial Personnel (KMP) at Suven Pharmaceuticals Limited India are P Rao SERVING AS THE CHIEF FINANCIAL OFFICER (CFO) and Hanumantha Kokkonda as Company Secretary. Govinda Dasu, Venkateswarlu Jasti, Srivari Chandrasekhar, and Four other members serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    suvenpharm.com

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24299TG2018PLC128171

  • Company No.

    128171

  • Stock Symbol

    BSE : 543064 NSE : SUVENPHAR

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    06 Nov 2018

  • Date of AGM

    31 Aug 2021

  • Date of Balance Sheet

    31 Mar 2021

  • Listing Status

    Listed

  • ROC Code

    Roc-Hyderabad

Industry

Pharma

What products or services does Suven Pharmaceuticals Limited offer?

Suven Pharmaceuticals Limited offers a wide range of products and services, including Cleaning Chemicals, Activation Powder, Cleaning Machines & Equipments, Industrial Cleaning Machine, Syringes, Insulin Syringe.

Who are the key members and board of directors at Suven Pharmaceuticals?

Executive Team (3)

NameDesignationAppointment DateStatus
Venkateswarlu Jasti Country flag representing Us Managing Director06-Nov-2019Current
P Rao Country flag representing In CFO(Kmp)10-Jan-2020Current
Hanumantha Kokkonda Country flag representing In Company Secretary10-Jan-2020Current

Board Members (6)

NameDesignationAppointment DateStatus
Vajja Rao Country flag representing In Director 23-Jul-2021Current
Srivari Chandrasekhar Country flag representing In Director 06-Nov-2019Current
Govinda Dasu Country flag representing In Director 06-Nov-2018Current
Deepanwita Chattopadhyay Country flag representing In Director 06-Nov-2019Current
Venkata Jasthi Country flag representing In Director 06-Nov-2019Current
Jerry Jeyasingh Country flag representing In Director 06-Nov-2019Current

Financial Performance of Suven Pharmaceuticals.

Suven Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.27% increase. The company also saw a substantial improvement in profitability, with a 80.82% increase in profit. The company's net worth Soared by an impressive increase of 42.76%.

Suven Pharmaceuticals revenue growth over time
Suven Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
47.27%
Revenue from Operations
30.75%
Total Assets
32.56%
Profit or Loss
80.82%
Net Worth
42.76%
EBITDA
59.62%

What is the Ownership and Shareholding Structure of Suven Pharmaceuticals?

In 2021, Suven Pharmaceuticals had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹174.02 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • State Bank Of India : 164.02 Cr
  • Bank Of Bahrain And Kuwait Bsc : 10.00 Cr

Latest Charge Details

DateLenderAmountStatus
29 Dec 2020Bank Of Bahrain And Kuwait Bsc₹10.00 CrOpen
05 Nov 2020State Bank Of India₹164.02 CrOpen

How Many Employees Work at Suven Pharmaceuticals?

Suven Pharmaceuticals has a workforce of 877 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Suven Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Suven Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suven Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Suven Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Suven Pharmaceuticals Limited last Annual general meeting of members was held on 31 Aug 2021 as per latest MCA records.

  • Balance Sheet

    Suven Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with RoC-Hyderabad.

  • Charges

    A charge with Bank Of Bahrain And Kuwait Bsc amounted to Rs. 10.00 Cr with Charge ID 100402459 was registered on 29 Dec 2020.

  • Charges

    A charge with State Bank Of India of Rs. 164.02 Cr registered on 05 Nov 2020 with Charge ID 100391471 was modified on 28 Dec 2020.

  • Charges

    A charge with State Bank Of India amounted to Rs. 164.02 Cr with Charge ID 100391471 was registered on 05 Nov 2020.

  • Director Appointment

    Venkateswarlu Jasti was appointed as a Managing Director was appointed as a Managing Director on 06 Nov 2019 & has been associated with this company since 5 years 3 months .

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Suven Pharmaceuticals Limited?

    Suven Pharmaceuticals Limited was incorporated on 06 Nov 2018.

  • What is authorized share capital and paid-up capital of Suven Pharmaceuticals Limited?

    The authorized share capital of Suven Pharmaceuticals Limited is ₹ 40.00 Cr and paid-up capital is ₹ 25.46 Cr.

  • Who are the current board members & directors of Suven Pharmaceuticals Limited?

    Currently 9 directors are associated with Suven Pharmaceuticals Limited.

    • Govinda Prasad Dasu
    • Venkateswarlu Jasti
    • Srivari Chandrasekhar
    • Deepanwita Chattopadhyay
    • Venkata Ramudu Jasthi
    • Jerry Jeyasingh
    • P Subba Rao
    • Hanumantha Rao Kokkonda
    • Vajja Sambasiva Rao

  • What is the registered address of Suven Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Suven Pharmaceuticals Limited is # 8-2-334 Sde Serene Chambers 3Rd Floor, Avenue 7 Road No. 5 Banjara Hills, Hyderabad, Telangana, India, 500034.

  • What is the corporate identification number (CIN) and company number of Suven Pharmaceuticals Limited?

    The corporate identification number (CIN) of Suven Pharmaceuticals Limited is U24299TG2018PLC128171 and the company number is 128171 as per Ministry of Corporate Affairs (MCA).

  • Is Suven Pharmaceuticals Limited registered with any stock exchange in India?

    Yes, Suven Pharmaceuticals Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): SUVENPHAR.

  • What is the official website of Suven Pharmaceuticals Limited?

    The Official website of Suven Pharmaceuticals Limited is https://www.suvenpharm.com

  • What has been the recent revenue trend for Suven Pharmaceuticals Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Suven Pharmaceuticals Limited has risen by 47.27%.

  • How many employees does Suven Pharmaceuticals Limited currently have?

    As Per 2022 financial reports, 877 employees are currently employed by Suven Pharmaceuticals Limited.

  • What change has been observed in the net worth of Suven Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Suven Pharmaceuticals Limited has experienced an upsurge of 42.76%.

  • What are the total open charges for Suven Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2022, The total open charges for Suven Pharmaceuticals Limited amount to ₹ 174.02 Cr.

  • When was the last Balance Sheet of Suven Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Suven Pharmaceuticals Limited was filed with the ROC on 31 Mar 2021.

People also Viewed

Similar Companies Based on Pharmaceutical Formulations